Clinical Trials in Baltimore

Showing 7661-7680 of 23,476 trials

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

NCT03165526

FDA issued a Humanitarian Device Exemption (HDE) approval order for the AMPLATZER™ PIVSD Occluder (H070005) on January 10, 2017. The Conditions of Approval require that SJM conduct a post approval study to evaluate the safety and probable benefit of the AMPLATZER™ PIVSD Occluder.

Post-Infarction Ventricular Septal Defect

Abbott Medical Devices131 participantsStarted Oct 2018

San Francisco, California, United States • Gainesville, Florida, United States • Baltimore, Maryland, United States +14 more locations

TERMINATEDPhase 1< 1 mile

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

NCT04749433

The goal of this study is to evaluate the safety of using the \[5-cyano-N-(4-(4-\[11C\]Methylpiperazin-1-yl)-2-(Piperidin-1-yl)Phenyl)Furan-2-carboxamide\] (\[11C\]CPPC) radiotracer in positron emission tomography (PET) imaging of people with amyotrophic lateral sclerosis (ALS). The investigators are also interested to see whether use of this radiotracer reveals imaging differences between patients with ALS and healthy patients.

Amyotrophic Lateral Sclerosis

Johns Hopkins University4 participantsStarted Sep 2021

Baltimore, Maryland, United States

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

Find Trials by Condition in Baltimore

Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study

Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

A Randomized Trial of Recruitment Strategies for Research Participation

LEGION™ Primary Safety and Efficacy

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Investigating Social Competence in Youth With Autism

Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)